glp 1 agonist cardiovascular outcomes Risks after GLP-1 Discontinuation Cardiovascular and renal outcomes of

Yang, F., Xiao, K., Pan, H

An observational study of obese T2D patients with concurrent MASLD (metabolic dysfunction-associated steatotic liver disease) showed that 12 weeks of liraglutide significantly increased gut bacterial diversity and shifted the community toward a profile more like healthy individuals (39)

A deficiency in vitamin B12 can lead to various health problems, including anemia and neurological issues, making supplementation with Cyanocobalamin a critical treatment for many individuals

JRSM Cardiovasc Dis

Bypassing major venous occlusion and duodenal lesions in rats, and therapy with the stable gastric pentadecapeptide BPC 157 L-NAME and L-arginine